logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
21/05/2025
The Malaysian Ringgit to US Dollar exchange rate has increased by 0.5% to 1 US Dollar to 4.2740 Malaysian Ringgit.
Latest
4 m ago
Price of Vanke Corporation VNKRLE 3.975 11/09/27 rose by 1.173% to 84.000.
4 m ago
Movement in US dollar bonds | Sunac China's SUNAC 0 09/30/28 price increased by 2.128% to reach 12.000.
5 m ago
Roche announced that the Phase III TALENTACE study has reached its primary endpoint. The study evaluated the efficacy and safety of atezolizumab, bevacizumab, and on-demand transarterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma (HCC) who have not received prior systemic therapy. The study showed a statistically and clinically significant improvement in TACE-induced progression-free survival (TACE-PFS, defined as the time from randomization to the investigator-assessed TACE-unrecoverable progression or TACE failure/resistance, or death for any reason) at the time of the interim analysis, with overall survival (OS) data still immature. Furthermore, a clinically meaningful improvement in PFS assessed by RECIST v1.1 was also observed.
5 m ago
Roche: The clinical study of liver cancer stage III TALENTACE has achieved the main research endpoint.
5 m ago
Former chairman Zhou Yiming of Sichuan Province International Supply Chain Management Co., Ltd. is under investigation.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.